Saturday, 16 July 2022

Study on Customized Assisted Reproduction Enhancement (CARE) for Women with Extremely Poor Ovarian Reserve (EPOR) | Chapter 2 | Emerging Trends in Disease and Health Research Vol. 9

Ovarian reserve is often evaluated using the quantity of ovarian antral follicles and blood levels of anti-Müllerian hormone (AMH). Women with moderately impaired ovarian reserve (AMH 0.2ng/ml and 1.1ng/ml) have a poor chance of becoming pregnant through in vitro fertilisation because of a low response to ovarian stimulation (IVF). Mixed findings have been found in studies attempting to predict the likelihood of pregnancy for women with extremely low ovarian reserve (AMH 0.2ng/ml). Many medical facilities throughout the globe reject patients with very poor ovarian reserve (EPOR), arguing that they have little prospect of recovery. According to this study, this group of women can obtain a relatively high clinical pregnancy rate (23 percent) and delivery rate with tailored aided reproductive enhancement (CARE) (18 percent). The CARE protocol individualises the patient's care during the pre-stimulation period, ovarian stimulation, embryological laboratory testing, and patient follow-up following embryo transfer.


Author (s) Details:

Jan Tesarik,
MAR Gen Clinic Granada, Spain.

Please see the link here:
https://stm.bookpi.org/ETDHR-V9/article/view/7440

No comments:

Post a Comment